If you’ve ever wondered why a simple inhaler can cost more than a month’s rent for some Nigerians, you’re not alone. In August 2024 we published a deep dive into the sudden surge of asthma medication prices after big pharmaceutical companies started pulling out of the market.
First off, when big pharma leaves, local distributors lose bulk‑buy power. That means they have to buy smaller batches at higher unit costs and pass those costs onto patients. On top of that, import taxes and shipping delays add another layer of expense. The result? A price jump that can be double or even triple the previous cost.
Patients are feeling the pinch fast. Many report skipping doses because they simply cannot afford their inhalers each month. Others turn to unregulated online sellers, hoping for a cheaper fix but risking counterfeit drugs. Both choices put health at serious risk.
The good news is that solutions are already being discussed. Local manufacturers are exploring generic production, which could bring prices down if quality standards are met. NGOs and government agencies are also stepping in with subsidy programs aimed at the most vulnerable families.
If you or someone you know is struggling, here are a few practical steps to consider:
While the situation is far from ideal, staying informed and proactive can make a big difference. Keep an eye on our updates for new policies, price‑watch tools, and stories of patients who have found ways to manage despite the odds.
We’ll keep covering this issue as it evolves because health shouldn’t be a luxury. If you’ve got questions or want to share your experience, drop us a comment below – we’re all in this together.
Pharmaceutical companies are exiting Nigeria, leading to a sharp increase in asthma medication costs and a growing health crisis. Patients now face severe difficulties accessing affordable treatments, forcing many to seek expensive alternatives. The broader implications for Nigeria's healthcare system are troubling, highlighting an urgent need for sustainable solutions to support asthma sufferers.